Company Filing History:

8 out of 382

Meiji Seika Kaisha, Ltd.

patents

1 out of 32

Meiji Seika Kabushiki Kaisha

patents

1 out of 12

Drug Delivery System Institute, Ltd.

patents

4. 1 out of 1

Meiji Saika Kaisha, Ltd.

patent

5. 1 out of 212

Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai

patents

where one patent can have more than one assignee

Years Active: 1979-1998

Loading Chart...

11 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 5786387 - Lipid double-chain derivative containing polyoxyethylene (1998-07-28),

2. 5250545 - Cancer cell metastasis inhibitor methods (1993-10-05),

3. 5243035 - Sialic acid-containing glycolipid derivatives (1993-09-07),

4. 5028601 - Cephalosporin compounds and antibacterial agents (1991-07-02),

5. 4985445 - Cancer cell metastasis inhibitors and novel compounds (1991-01-15),

6. 4954510 - Antiviral agent containing lactam compound (1990-09-04),

7. 4785090 - Cephalosporin derivatives (1988-11-15),

8. 4225706 - Polychalcogen ester of cephem compound, process for preparing the same (1980-09-30),

9. 4188480 - Process for the production of a 9,3'-di-acyl derivative of a macrolide (1980-02-12),

10. 4175185 - Process for preparing cephalosporanic acid derivatives (1979-11-20),

11. 4159372 - Process for preparing cephalosporin esters in the presence of liquid (1979-06-26),

Title: Satoru Nakabayashi: Innovator in Cancer Research

Introduction

Satoru Nakabayashi is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of cancer research, holding a total of 11 patents. His work focuses on innovative methods to inhibit cancer cell metastasis, showcasing his dedication to advancing medical science.

Latest Patents

Among his latest patents are groundbreaking inventions such as a lipid double-chain derivative containing polyoxyethylene and various sugar lactams. These include N-(3-phenylpropyl)-1-deoxynojirimycin, 1-deoxynojirimycin, D-glucaro-.delta.-lactam, and 6-O-triphenylmethyl-D-gluco-.delta.-lactam. These inventions are designed to inhibit the metastasis of cancer cells, highlighting Nakabayashi's commitment to combating cancer.

Career Highlights

Throughout his career, Satoru Nakabayashi has worked with notable companies, including Meiji Seika Kaisha, Ltd. and Meiji Seika Kabushiki Kaisha. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to his success as an inventor.

Collaborations

He has collaborated with esteemed colleagues such as Shinichi Kondo and Shunzo Fukatsu. These partnerships have further enriched his research and development efforts in the field of cancer treatment.

Conclusion

Satoru Nakabayashi's contributions to cancer research through his patents and collaborations demonstrate his significant impact on the field. His innovative approaches continue to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.